Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

BACKGROUND: We examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus (DM). METHODS AND RESULTS: We conducted a cohort study of patients with rheumatoid arthritis who newly started ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Eun Ha, Jin, Yinzhu, Brill, Gregory, Lewey, Jennifer, Patorno, Elisabetta, Desai, Rishi J., Kim, Seoyoung C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850244/
https://www.ncbi.nlm.nih.gov/pubmed/29367417
http://dx.doi.org/10.1161/JAHA.117.007393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850244/
https://www.ncbi.nlm.nih.gov/pubmed/29367417
http://dx.doi.org/10.1161/JAHA.117.007393

Ejemplares similares